Strategic Advisors


Reginald M. Ballantyne III, FACHE – Strategic Advisor

Reginald Ballantyne is the former Senior Strategic Advisor for Dallas-based Tenet Healthcare Corporation, a national hospital and healthcare services company that acquired Vanguard Health Systems, for which he had served as Senior Corporate office for more than a decade. Prior to Vanguard, Mr. Ballantyne was President and CEO of PMH Health Resources. He is now a consultant and advocate for business and government entities interested in collaborative ideas and ventures in the areas of healthcare, policy and innovation. His background includes numerous advisory roles and awards, and includes service as both Speaker of the House as well as Chairman of the American Hospital Association.

Vishu J. Jhaveri, MD, MSA – Strategic Advisor

Dr. Jhaveri is senior vice president of health services, network management and chief medical officer at Blue Cross Blue Shield of Arizona, where he manages accreditation, medical underwriting, medical claims review, clinical quality improvement, care management, disease management, health promotion/wellness, utilization review, provider credentialing, network services and contracting.  Dr. Jhaveri is a board certified pediatrician and has spent 17 years in direct patient care.

Michael Doherty – Strategic Advisor

Michael Doherty has 25 years of global pharmaceuticals industry experience including the most recent 14 years at Roche Pharmaceuticals and Genentech as Head of Regulatory Affairs overseeing the approvals of products in the field of oncology, immunology, hematology and bone disease. He is currently Head of Product Development at Foundation Medicine, where he leads a team dedicated to the introduction of clinical and data products in the field of cancer genomics based on Next-Generation Sequencing. Mr. Doherty serves as a Regulatory Strategy Advisory advisor to VisionGate, Inc., as a Strategic Advisor to Genentech Product Development and on the advisory board of IBM Watson Life Sciences.


This website may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and made in reliance on the "safe harbor" provisions of said act. Forward-looking statements are based on estimates, projections, beliefs and assumptions of VisionGate® management at the time of such statements and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties in predicting future results and conditions. Actual results could differ materially from those projected in these forward-looking statements due to a variety of factors, including, without limitation, the acceptance by customers of our products, our ability to develop new products cost-effectively, our ability to raise capital in the future, the development by competitors of products using improved or alternative technology, the retention of key employees and general economic conditions. Forward-looking statements are subject to change without notice.

Contact Us

If you are interested in learning more about VisionGate and would like to speak with someone, please complete this short inquiry form and a representative will contact you as soon as possible.


Copyright 2017 - VisionGate, Inc.